Astrana Health (NASDAQ:ASTH) Beats Q3 Sales Expectations [Yahoo! Finance]
Astrana Health Inc. (ASTH)
Company Research
Source: Yahoo! Finance
On the other hand, the company's full-year revenue guidance of $3.14 billion at the midpoint came in 2.2% below analysts' estimates. Its GAAP profit of $0.01 per share was 97.6% below analysts' consensus estimates. Is now the time to buy Astrana Health? Find out in our full research report Astrana Health (ASTH) Q3 CY2025 Highlights: Closes Prospect Health acquisition Revenue: $956 million vs analyst estimates of $950.2 million (99.7% year-on-year growth, 0.6% beat) EPS (GAAP): $0.01 vs analyst expectations of $0.43 (97.6% miss) Adjusted EBITDA: $68.48 million vs analyst estimates of $67.29 million (7.2% margin, 1.8% beat) The company dropped its revenue guidance for the full year to $3.14 billion at the midpoint from $3.2 billion, a 1.9% decrease EBITDA guidance for the full year is $205 million at the midpoint, below analyst estimates of $220 million Operating Margin: 2%, down from 5.9% in the same quarter last year Free Cash Flow Margin: 0.8%, down from 6.6% in t
Show less
Read more
Impact Snapshot
Event Time:
ASTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASTH alerts
High impacting Astrana Health Inc. news events
Weekly update
A roundup of the hottest topics
ASTH
News
- Astrana Health (NASDAQ:ASTH) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..MarketBeat
- Astrana Health (NASDAQ:ASTH) was given a new $37.00 price target on by analysts at Jefferies Financial Group Inc..MarketBeat
- Astrana Health (NASDAQ:ASTH) was given a new $26.00 price target on by analysts at Barclays PLC.MarketBeat
- A Look at Astrana Health's (ASTH) Valuation Following Earnings Miss and Lowered Guidance [Yahoo! Finance]Yahoo! Finance
- Astrana Health (NASDAQ:ASTH) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d+)" rating.MarketBeat